New products
CereVasc concludes patient enrolment in STRIDE trial of eShunt
CereVasc has completed patient enrollment in the STRIDE clinical trial evaluating its eShunt system for normal pressure hydrocephalus (NPH). The study assesses safety and efficacy of the device ahead of regulatory submissions.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network